Cargando…

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)

Detalles Bibliográficos
Autor principal:	Lu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800963/ https://www.ncbi.nlm.nih.gov/pubmed/36589838 http://dx.doi.org/10.3389/fendo.2022.1074842

Ejemplares similares

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation
por: Ren, Yakun, et al.
Publicado: (2022)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2022)

FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
por: Itoh, Nobuyuki
Publicado: (2014)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2023)

Physiological Roles of Adipokines, Hepatokines, and Myokines in Ruminants
por: Roh, Sang-Gun, et al.
Publicado: (2016)

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
por: de Oliveira dos Santos, Ana Rita, et al.
Publicado: (2021)

Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines
por: Oh, Kyoung-Jin, et al.
Publicado: (2016)

Adipokine-myokine-hepatokine compartment-system in mothers and children: An explorative study
por: Deibert, Clara, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Role of Hepatokines in Non-alcoholic Fatty Liver Disease
por: Ke, Yini, et al.
Publicado: (2019)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors
por: Alizadeh Pahlavani, Hamed
Publicado: (2022)

Editorial: The liver as an endocrine organ: Hepatokines and ketone bodies, novel hormones to be acknowledged
por: Risi, Renata, et al.
Publicado: (2023)

Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology
por: Di Felice, Valentina, et al.
Publicado: (2020)

The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
por: Gonzalez-Gil, Adrian M., et al.
Publicado: (2020)

Editorial: Roles and mechanisms of adipokines in metabolic diseases
por: Xie, Liwei, et al.
Publicado: (2023)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects
por: Li, Zhanghao, et al.
Publicado: (2023)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
por: Senesi, Pamela, et al.
Publicado: (2020)

Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology, Volume II
por: Di Felice, Valentina, et al.
Publicado: (2022)

The Role of Myokines and Adipokines in Hypertension and Hypertension-related Complications
por: Chen, Ken, et al.
Publicado: (2019)

The Hepatokine Adropin Is Regulated by Estrogen
por: Stokar, Joshua, et al.
Publicado: (2021)

THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
por: Venniyoor, Ajit, et al.
Publicado: (2021)

Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning
por: Cao, Yang, et al.
Publicado: (2023)

The Hepatokine FGF21 Increases the Human Spermatozoa Motility
por: Bourdon, Guillaume, et al.
Publicado: (2022)

Differences in Adipokine and Hepatokine Levels among Non-diabetic Population Classified by Age and Sex
por: Lee, Eun Soo, et al.
Publicado: (2013)

Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022)

THU585 Non-alcoholic Fatty Liver Disease (NAFLD), A Silent But Emerging Problem In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease
por: Mirza, M. S.
Publicado: (2011)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
por: Lv, Yingqi, et al.
Publicado: (2022)

Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
por: Adolph, Timon E., et al.
Publicado: (2017)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
por: Zyśk, Beata, et al.
Publicado: (2023)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans
por: Plomgaard, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tj4heb6t3ch7jd120467cfhsro